Utilizing postmortem drug concentrations in mechanistic modeling and simulation of cardiac effects: a proof of concept study with methadone

References

• Baselt R. 2014. Disposition of Toxic Drugs and Chemicals in Man. 10th ed. Seal Beach, CA, USA: Biomedical Publications.
   Google Scholar
• Bernard J-PP, Havnes I, Slørdal L, Waal H, Mørland J, Khiabani HZ. 2013. Methadone-related deaths in Norway. Forensic Sci Int. 224:111–116.
   PubMed Web of Science ®Google Scholar
• Carlquist JF, Moody DE, Knight S, Johnson EG, Fang WB, Huntinghouse JA, Rollo JS, Webster LR, Anderson JL. 2015. A possible mechanistic link between the CYP2C19 genotype, the methadone metabolite ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidene (EDDP), and methadone-induced corrected QT interval prolongation in a pilot study. Mol Diagn Ther. 19:131–138.
   PubMed Web of Science ®Google Scholar
• Cavero I, Holzgrefe H. 2015. CiPA: Ongoing testing, future qualification procedures, and pending issues. J Pharmacol Toxicol Methods. 76:27–37.
   PubMed Web of Science ®Google Scholar
• Chowdhury M, Wong J, Cheng A, Khilkin M, Palma E. 2015. Methadone therapy in underserved urban community: QTC prolongation and life-threatening ventricular arrhythmias. Cardiovasc Ther. 33:127–133.
   PubMed Web of Science ®Google Scholar
• Corkery JM, Schifano F, Ghodse HA, Oyefeso A. 2004. The effects of methadone and its role in fatalities. Hum Psychopharmacol. 19:565–576.
   PubMed Web of Science ®Google Scholar
• De Bels D, Staroukine M, Devriendt J. 2003. Torsades de pointes due to methadone. Ann Intern Med. 139:W-58.
   Google Scholar
• Eap CB, Crettol S, Rougier JS, Schläpfer J, Grilo SL, Déglon JJ, Besson J, Croquette‐Krokar M, Carrupt PA, Abriel H. 2007. Stereoselective Block of hERG Channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers. Clin Pharmacol Ther. 81:719–728.
   PubMed Web of Science ®Google Scholar
• Eap CB, Cuendet C, Baumann P. 1990. Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein. Clin Pharmacol Ther. 47:338–346.
   PubMed Web of Science ®Google Scholar
• Ehret GB, Voide C, Gex-Fabry M, Chabert J, Shah D, Broers B, Piguet V, Musset T, Gaspoz J-M, Perrier A. 2006. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Arch Intern Med. 166:1280–1287.
   PubMed Web of Science ®Google Scholar
• Fanoe S, Hvidt C, Ege P, Jensen GB. 2007. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart. 93:1051–1055.
   PubMed Web of Science ®Google Scholar
• Fanoe S, Jensen G, Sjøgren P, Korsgaard MPG, Grunnet M. 2009. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro. Br J Clin Pharmacol. 67:172–179.
   PubMed Web of Science ®Google Scholar
• Glinka A, Polak S. 2013. An analysis of cardiomyocytes’ electrophysiology in the presence of the hERG gene mutations. Bio-Algorithms and Med-Systems. 9:135–140.
   Google Scholar
• Handley SA, Flanagan RJ. 2014. Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000–2011. Clin Toxicol (Phila). 52:1–12.
   PubMed Web of Science ®Google Scholar
• Holm KMD, Linnet K. 2016. Determination of the unbound fraction of R- and S-methadone in human brain. Int J Legal Med. 130:1519–1526.
   PubMed Web of Science ®Google Scholar
• Kalvass JC, Maurer TS. 2002. Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery. Biopharm Drug Dispos. 23:327–338.
   PubMed Web of Science ®Google Scholar
• Katchman AN, McGroary KA, Kilborn MJ, Kornick CA, Manfredi PL, Woosley RL, Ebert SN. 2002. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther. 303:688–694.
   PubMed Web of Science ®Google Scholar
• Kornick CA, Kilborn MJ, Santiago-Palma J, Schulman G, Thaler HT, Keefe DL, Katchman AN, Pezzullo JC, Ebert SN, Woosley RL, et al. 2003. QTc interval prolongation associated with intravenous methadone. Pain. 105:499–506.
   PubMed Web of Science ®Google Scholar
• Kramer J, Obejero-Paz CA, Myatt G, Kuryshev YA, Bruening-Wright A, Verducci JS, Brown AM. 2013. MICE models: superior to the HERG model in predicting torsade de pointes. Sci Rep. 3:2100.
   PubMed Web of Science ®Google Scholar
• Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. 2002. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med. 137:501–504.
   PubMed Web of Science ®Google Scholar
• Kuryshev Y, Bruening-Wright A, Brown A, Kirsch G, Kuryshev Y, Bruening-Wright A, Brown A, Kirsch G. 2010. Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels. J Cardiovasc Pharmacol. 56:420–430.
   PubMed Web of Science ®Google Scholar
• Lehotay DC, George S, Etter ML, Graybiel K, Eichhorst JC, Fern B, Wildenboer W, Selby P, Kapur B. 2005. Free and bound enantiomers of methadone and its metabolite, EDDP in methadone maintenance treatment: relationship to dosage? Clin Biochem. 38:1088–1094.
   PubMed Web of Science ®Google Scholar
• Lombardo DM, Fenton FH, Narayan SM, Rappel W-J. 2016. Comparison of detailed and simplified models of human atrial myocytes to recapitulate patient specific properties. PLoS Comput Biol. 12:e1005060.
   PubMed Web of Science ®Google Scholar
• Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN. 2005. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol. 95:915–918.
   PubMed Web of Science ®Google Scholar
• Mikkelsen CR, Jornil JR, Andersen LV, Banner J, Hasselstrøm JB. 2016. Quantification of 16 QT-prolonging drugs and metabolites in human postmortem blood and cardiac tissue using UPLC-MS-MS. J Anal Toxicol. 40:286–293.
   PubMed Web of Science ®Google Scholar
• Mikkelsen CR, Jornil JR, Andersen LV, Banner J, Hasselstrøm JB. 2018. Distribution of eight QT-prolonging drugs and their main metabolites between postmortem cardiac tissue and blood reveals potential pitfalls in toxicological interpretation. J Anal Toxicol. Advance Access, published March 20, 2018, doi: https://doi.org/10.1093/jat/bky018.
   PubMed Web of Science ®Google Scholar
• Niederer SA, Fink M, Noble D, Smith NP. 2009. A meta-analysis of cardiac electrophysiology computational models. Exp Physiol. 94:486–495.
   PubMed Web of Science ®Google Scholar
• O'Hara T, Virág L, Varró A, Rudy Y. 2011. Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation potential: model formulation and experimental validation. PLoS Comput Biol. 7:e1002061.
   PubMed Web of Science ®Google Scholar
• Okada J-I, Yoshinaga T, Kurokawa J, Washio T, Furukawa T, Sawada K, Sugiura S, Hisada T. 2015. Screening system for drug-induced arrhythmogenic risk combining a patch clamp and heart simulator. Sci Adv. 1:e1400142.
   PubMed Web of Science ®Google Scholar
• Okic M, Cnossen L, Crifasi JA, Long C, Mitchell EK. 2013. Opioid overdose mortality in Kansas, 2001–2011: toxicologic evaluation of intent. J Anal Toxicol. 37:629–635.
   PubMed Web of Science ®Google Scholar
• Passini E, Britton OJ, Lu HR, Rohrbacher J, Hermans AN, Gallacher DJ, Greig RJH, Bueno-Orovio A, Rodriguez B. 2017. Human in silico drug trials demonstrate higher accuracy than animal models in predicting clinical pro-arrhythmic cardiotoxicity. Front Physiol. 8:668.
   PubMed Web of Science ®Google Scholar
• Patel N, Wiśniowska B, Jamei M, Polak S. 2017. Real patient and its virtual twin: application of quantitative systems toxicology modelling in the cardiac safety assessment of citalopram. AAPS J. 20:6.
   PubMed Web of Science ®Google Scholar
• Peles E, Bodner G, Kreek M, Rados V, Adelson M. 2007. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Addiction. 102:289–300.
   PubMed Web of Science ®Google Scholar
• Polak S, Fijorek K, Glinka A, Wisniowska B, Mendyk A. 2012. Virtual population generator for human cardiomyocytes parameters: in silico drug cardiotoxicity assessment. Toxicol Mech Methods. 22:31–40.
   PubMed Web of Science ®Google Scholar
• Romach MK, Piafsky KM, Abel JG, Khouw V, Sellers EM. 1981. Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma. Clin Pharmacol Ther. 29:211–217.
   PubMed Web of Science ®Google Scholar
• Simcyp. 2016. Cardiac Safety Simulator. https://www.certara.com/software/pbpk-modeling-and-simulation/cardiac-safety-simulator/
   Google Scholar
• Simcyp Limited. 2018. ADME Calculators – B/P prediction. Simcyp Limited; [accessed 2016 Jul 11]. https://members.simcyp.com/account/tools/BP/
   Google Scholar
• Simonsen KW, Edvardsen HME, Thelander G, Ojanperä I, Thordardottir S, Andersen LV, Kriikku P, Vindenes V, Christoffersen D, Delaveris GJM, Frost J. 2015. Fatal poisoning in drug addicts in the Nordic countries in 2012. Forensic Sci Int. 248:172–180.
   PubMed Web of Science ®Google Scholar
• Sjögren AL. 1971. Left ventricular wall thickness determined by ultrasound in 100 subjects without heart disease. Chest. 60:341–346.
   PubMed Web of Science ®Google Scholar
• Skjervold B, Bathen J, Spigset O. 2006. Methadone and the QT interval: relations to the serum concentrations of methadone and its enantiomers (R)-methadone and (S)-methadone. J Clin Psychopharmacol. 26:687–688.
   PubMed Web of Science ®Google Scholar
• Smith DA, Di L, Kerns EH. 2010. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov. 9:929–939.
   PubMed Web of Science ®Google Scholar
• Stallvik M, Nordstrand B, Kristensen Ø, Bathen J, Skogvoll E, Spigset O. 2013. Corrected QT interval during treatment with methadone and buprenorphine-relation to doses and serum concentrations. Drug Alcohol Depend. 129:88–93.
   PubMed Web of Science ®Google Scholar
• ten Tusscher K, Noble D, Noble PJ, Panfilov AV. 2004. A model for human ventricular tissue. Am J Physiol Heart Circ Physiol. 286:H1573–H1589.
   PubMed Web of Science ®Google Scholar
• Testai L, Bianucci AM, Massarelli I, Breschi MC, Martinotti E, Calderone V. 2004. Torsadogenic cardiotoxicity of antipsychotic drugs: a structural feature, potentially involved in the interaction with cardiac HERG potassium channels. Curr Med Chem. 11:2691–2706.
   PubMed Web of Science ®Google Scholar
• Titier K, Déridet E, Moore N. 2002. In vivo and in vitro myocardial binding of risperidone and 9-hydroxyrisperidone. Toxicol Appl Pharmacol. 180:145–149.
   PubMed Web of Science ®Google Scholar
• Trayanova NA, Boyle PM. 2014. Advances in modeling ventricular arrhythmias: from mechanisms to the clinic. Wiley Interdiscip Rev Syst Biol Med. 6:209–224.
   PubMed Web of Science ®Google Scholar
• Wikner BN, Öhman I, Seldén T, Druid H, Brandt L, Kieler H. 2014. Opioid-related mortality and filled prescriptions for buprenorphine and methadone. Drug Alcohol Rev. 33:491–498.
   PubMed Web of Science ®Google Scholar
• Zünkler BJ, Wos-Maganga M. 2010. Comparison of the effects of methadone and heroin on human ether-à-go-go-related gene channels. Cardiovasc Toxicol. 10:161–165.
   PubMed Web of Science ®Google Scholar